Integrated Filing-Governance



General information about company

Scrip Code 540975
NSE Symbol ASTERDM
MSEI Symbol NOTLISTED
ISIN INE914M01019
Name of the entity Aster DM Healthcare Limited
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Reporting Quarter Yearly
Date of Quarter Ending 31-Mar-2026
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? Yes
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? No
Reason For Part D Of Annexure I Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity No such instance to report.
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? Yes
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity? No
Reason For Part F Of Annexure I Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity No such instance to report
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 500 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID a01103
Reason For No SCORE ID
Type of Submission New
Remarks (website dissemination)



Annexure I

Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO Yes Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. MANDAYAPURATH AZAD MOOPEN 00159403 Executive Director Chairperson MD 15-Apr-1953 No Active NA 01-Dec-2014 15-Apr-2023 1 0 0 0
2 Ms. ALISHA MOOPEN 02432525 Executive Director Not Applicable 11-Jul-1981 No Active NA 07-Aug-2019 07-Aug-2024 1 0 1 0
3 Mr. THADATHIL JOSEPH WILSON 02135108 Non-Executive - Non Independent Director Not Applicable 14-May-1961 No Active NA 20-Apr-2009 1 0 2 0
4 Mr. SHAMSUDHEEN BIN MOHIDEEN MAMMU HAJI 02007279 Non-Executive - Non Independent Director Not Applicable 26-May-1963 No Active NA 16-Sep-2015 1 0 0 0
5 Ms. ZEBA AZAD MOOPEN 03604401 Non-Executive - Non Independent Director Not Applicable 19-Sep-1990 No Active NA 31-Jul-2024 1 0 0 0
6 Mr. JAMES MATHEW 07572909 Non-Executive - Independent Director Not Applicable 25-May-1966 No Active NA 23-Jun-2020 23-Jun-2023 69.8 1 1 2 2
7 Mr. SUNIL THECKATH VASUDEVAN 00294130 Non-Executive - Independent Director Not Applicable 03-Mar-1966 No Active NA 31-Jul-2024 31-Jul-2024 20 1 1 1 0
8 Mr. CHENAYAPPILLIL JOHN GEORGE 00003132 Non-Executive - Independent Director Not Applicable 22-Mar-1959 No Active NA 11-Apr-2020 11-Apr-2023 71.2 2 1 2 0
9 Ms. PURANA HOUSDURGAMVIJAYA DEEPTI 08125456 Non-Executive - Independent Director Not Applicable 18-Oct-1961 No Active NA 27-Mar-2023 27-Mar-2023 36.4 1 1 3 1
10 Mr. MANIEDATH MADHAVAN NAMBIAR 01122411 Non-Executive - Independent Director Not Applicable 09-Nov-1950 No Active Yes 29-Aug-2024 31-Jul-2024 31-Jul-2024 20 1 1 1 1



Annexure 1

II. Composition of Committees

Disclosure of notes on composition of committees explanatory



Audit Committee Details

Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 07572909 JAMES MATHEW Non-Executive - Independent Director Chairperson 12-Aug-2020
2 02432525 ALISHA MOOPEN Executive Director Member 28-May-2019
3 00294130 SUNIL THECKATH VASUDEVAN Non-Executive - Independent Director Member 14-Oct-2024



Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00294130 SUNIL THECKATH VASUDEVAN Non-Executive - Independent Director Chairperson 09-Nov-2025
2 08125456 PURANA HOUSDURGAMVIJAYA DEEPTI Non-Executive - Independent Director Member 27-Mar-2023
3 01122411 MANIEDATH MADHAVAN NAMBIAR Non-Executive - Independent Director Member 14-Oct-2024
4 02135108 THADATHIL JOSEPH WILSON Non-Executive - Non Independent Director Member 09-Nov-2025



Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 07572909 JAMES MATHEW Non-Executive - Independent Director Chairperson 12-Aug-2020
2 02135108 THADATHIL JOSEPH WILSON Non-Executive - Non Independent Director Member 21-Apr-2015
3 00003132 CHENAYAPPILLIL JOHN GEORGE Non-Executive - Independent Director Member 11-Nov-2021



Risk Management Committee

Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 08125456 PURANA HOUSDURGAMVIJAYA DEEPTI ID Chairperson 25-May-2023
2 02135108 THADATHIL JOSEPH WILSON NED Member 28-May-2019
3 07572909 JAMES MATHEW ID Member 12-Aug-2020
4 02432525 ALISHA MOOPEN ED Member 28-May-2019
5 03604401 ZEBA AZAD MOOPEN NED Member 14-Oct-2024



Annexure 1

III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 06-Nov-2025 Yes 12 11 6
2 30-Jan-2026 84 Yes 10 10 5
3 10-Mar-2026 38 Yes 10 9 4
4 26-Mar-2026 15 Yes 10 10 5



Annexure 1

IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 05-Nov-2025 Yes 4 4 3 0
2 Audit Committee 29-Jan-2026 84 Yes 3 3 2 0
3 Audit Committee 10-Mar-2026 39 Yes 3 3 2 0
4 Audit Committee 26-Mar-2026 15 Yes 3 3 2 0
5 Nomination and remuneration committee 05-Nov-2025 Yes 4 3 3 0
6 Nomination and remuneration committee 29-Jan-2026 84 Yes 4 4 3 0
7 Nomination and remuneration committee 04-Mar-2026 Yes 4 4 3 0
8 Stakeholders Relationship Committee 05-Nov-2025 Yes 4 3 2 0
9 Risk Management Committee 30-Mar-2026 Yes 5 3 2 0



Annexure 1

VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here:



Annexure 1

Sr Subject Compliance status
1 Name of signatory Hemish Purushottam
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence

Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of LODR Regulation
Sr Item Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here. Web address
1.1 Details of business Yes https://www.asterdmhealthcare.in/investors/about-asterdm
1.2 Memorandum of Association and Articles of Association Yes https://www.asterdmhealthcare.in/investors/corporate-governance/governance-documents-and-policies
1.3 Brief profile of board of directors including directorship and full time positions in body corporates Yes https://www.asterdmhealthcare.in/investors/corporate-governance/board-of-directors
2 Terms and conditions of appointment of independent directors Yes https://www.asterdmhealthcare.in/fileadmin/user_upload/AsterDM_Letter_Appointment_Independent_Director_08.pdf
3 Composition of various committees of board of directors Yes https://www.asterdmhealthcare.in/investors/corporate-governance/board-committees
4 Code of conduct of board of directors and senior management personnel Yes https://www.asterdmhealthcare.in/fileadmin/user_upload/Code_of_Conduct_for_Board_of_Directors_and_Sr_Management.pdf
5 Details of establishment of vigil mechanism or whistle blower policy Yes https://www.asterdmhealthcare.in/fileadmin/user_upload/Aster_Whistle_Blowing_Policy_.pdf
6 Criteria of making payments to non-executive directors Yes https://www.asterdmhealthcare.in/fileadmin/Policy_on_Nomination__Remuneration_and_Evaluation.pdf
7 Policy on dealing with related party transactions Yes https://www.asterdmhealthcare.in/fileadmin/AsterDMRPTPolicyJan302026.pdf
8 Policy for determining material subsidiaries Yes https://www.asterdmhealthcare.in/fileadmin/Policy_for_determining_Material_Subsidiaries_1.pdf
9 Details of familiarization programmes imparted to independent directors Yes https://www.asterdmhealthcare.in/investors/corporate-governance/governance-documents-and-policies
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes https://www.asterdmhealthcare.in/investor/contact-us
11 Email address for grievance redressal and other relevant details Yes https://www.asterdmhealthcare.in/investor/contact-us
12 Financial results Yes https://www.asterdmhealthcare.in/investors/financial-information/quarterly-reports
13 Shareholding pattern Yes https://www.asterdmhealthcare.in/investors/stock-exchange-disclosures/shareholding-pattern
14 Details of agreements entered into with the media companies and/or their associates NA
15.1 Schedule of analyst or institutional investor meet and presentation prepared by listed entity for analyst or institutional investor meet Yes https://www.asterdmhealthcare.in/investors/stock-exchange-disclosures/investor-meeting
15.2 Audio or video recordings and transcripts of post earnings/quarterly calls Yes https://www.asterdmhealthcare.in/investors/financial-information/earning-call-transcripts
16 New name and the old name of the listed entity NA
17 Advertisements as per regulation 47 (1) Yes https://www.asterdmhealthcare.in/investors/stock-exchange-disclosures/newspaper-advertisement
18 Credit rating or revision in credit rating obtained Yes https://www.asterdmhealthcare.in/investors/stock-exchange-disclosures/credit-ratings
19 Separate audited financial statements of each subsidiary of the listed entity Yes https://www.asterdmhealthcare.in/investors/financial-information/subsidiary-financials
20 Secretarial compliance report Yes https://www.asterdmhealthcare.in/investors/corporate-governance/secretarial-compliance-reports
21 Materiality policy as per regulation 30 (4) Yes https://www.asterdmhealthcare.in/fileadmin/user_upload/Aster_Policy_for_determination_of_materiality_.pdf
22 Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5) Yes https://www.asterdmhealthcare.in/investor/contact-us
23 Disclosures under regulation 30(8) Yes https://www.asterdmhealthcare.in/investors/stock-exchange-disclosures/other-announcement-and-disclosures
24 Statements of deviation(s) or variations(s) as specified in regulation 32 NA
25 Dividend distribution policy as specified in regulation 43A (1) Yes https://www.asterdmhealthcare.in/fileadmin/user_upload/Final_DDP_to_upload_on_website.pdf
26.1 Annual return as provided under section 92 of the Companies Act 2013 Yes https://www.asterdmhealthcare.in/investors/corporate-governance/annual-returns
26.2 Employee benefit scheme documents framed in terms of SEBI (SBEB) regulations 2021
27 Confirmation that the above disclosures are in a separate section as specified in regulation 46(2) Yes https://www.asterdmhealthcare.in/investors
28 Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updation Yes https://www.asterdmhealthcare.in/investors
29 Disclosure of notes on website in terms of Listing Regulations explanatory


Annexure II

II. Annual Affirmations
Sr Particulars Regulation Number Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here.
1 Independent director(s) have been appointed in terms of specified criteria of independence and/or eligibility 16(1)(b) Yes
2 Board Composition 17(1), 17(1A) & 17(1C), 17(1D) & 17(1E) Yes
3 Meeting Of Board Of Directors 17(2) Yes
4 Quorum of board meeting 17(2A) Yes
5 Review of Compliance Reports 17(3) Yes
6 Plans for orderly succession for appointments 17(4) Yes
7 Code of Conduct 17(5) Yes
8 Fees/compensation 17(6) Yes
9 Minimum Information 17(7) Yes
10 Compliance Certificate 17(8) Yes
11 Risk Assessment & Management 17(9) Yes
12 Performance Evaluation of Independent Directors 17(10) Yes
13 Recommendation of Board 17(11) Yes
14 Maximum number of Directorships 17A Yes
15 Composition of Audit Committee 18(1) Yes
16 Meeting of Audit Committee 18(2) Yes
17 Role of Audit Committee and information to be reviewed by the audit committee 18(3) Yes
18 Composition of nomination & remuneration committee 19(1) & (2) Yes
19 Quorum of Nomination and Remuneration Committee meeting 19(2A) Yes
20 Meeting of Nomination and Remuneration Committee 19(3A) Yes
21 Role of Nomination and Remuneration Committee 19(4) Yes
22 Composition of Stakeholder Relationship Committee 20(1), 20(2) & 20(2A) Yes
23 Meeting of Stakeholders Relationship Committee 20(3A) Yes
24 Role of Stakeholders Relationship Committee 20(4) Yes
25 Composition and role of risk management committee 21(1),(2),(3),(4) Yes
26 Meeting of Risk Management Committee 21(3A) Yes
27 Quorum of Risk Management Committee meeting 21(3B) Yes
28 Gap between the meetings of the Risk Management Committee 21(3C) Yes
29 Vigil Mechanism 22 Yes
30 Policy for related party Transaction 23(1), (1A), (5), (6), & (8) Yes
31 Prior or Omnibus approval of Audit Committee for all related party transactions 23(2), (3) Yes
32 Approval for material related party transactions 23(4) NA
33 Disclosure of related party transactions on consolidated basis 23(9) Yes
34 Composition of Board of Directors of unlisted material Subsidiary 24(1) Yes
35 Other Corporate Governance requirements with respect to subsidiary of listed entity 24(2),(3),(4),(5) & (6) Yes
36 Alternate Director to Independent Director 25(1) NA
37 Maximum Tenure 25(2) Yes
38 Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism 25(2A) Yes
39 Meeting of independent directors 25(3) & (4) Yes
40 Familiarization of independent directors 25(7) Yes
41 Declaration from Independent Director 25(8) & (9) Yes
42 Directors and Officers insurance 25(10) Yes
43 Confirmation with respect to appointment of Independent Directors who resigned from the listed entity 25(11) NA
44 Memberships in Committees 26(1) Yes
45 Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel 26(3) Yes
46 Policy with respect to Obligations of directors and senior management 26(2) & 26(5) Yes
47 Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity 26(6) NA
48 Vacancies in respect Key Managerial Personnel 26A(1) & 26A(2), 26A(3) Yes
Any other information to be provided - Add Notes



Annexure II
III. Affirmations
Sr Particulars Compliance status (Yes/No/NA)
1 The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied Yes
Any other information to be provided



Annexure II
1 Name of signatory Hemish Purushottam
2 Designation Company Secretary and Compliance Officer



Additional Half yearly Disclosure

Any Other Information for Disclosure of Loans / Guarantees / Comfort Letters / Securities Etc.
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.refer note below
(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(B) Any guarantee / comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed By
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(C) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(D) Additional Information
II. Affirmations
Affirmations Compliance Status Company Remarks
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. $intratedCg.get("CG_YN_$!integratedFillingMasterDto.cgMasterVO.anx4aAffirmComplStatus")
Name
Designation
Place
Date



Signatory Details

Name of signatory Hemish Purushottam
Designation of person Company Secretary and Compliance Officer
Place Bengaluru
Date 30-Apr-2026


Investor Grievance Details

No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below

Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies As a part of internal capital restructuring the Company, a loan of Rs.129.35 Cr extended by the Company to AMHPL has been converted into equity shares and accordinlgy issued 12,93,45,537 equity shares of face value Rs.10 each to the Company on 27 March 2026. No change in shareholding. The Company continues to hold 100% in the equity share capital of AMHPL.
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter
1 Aster DM Multispecialty Hospital Private Limited 27-Mar-2026 100 0 100


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:

Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute
1 Additional Commissioner of Income Tax 25-Nov-2011 Company claimed deduction of INR 2,96,353 while filing ITR. After filing the ITR, return was selected for scrutiny and notice u/s 142(1) was issued on 10th May 2011 requiring the Company to produce relevant books of accounts. Thereafter, another notice was issued on 22nd Sep 2011 and in response to the same, Company's authorised representative (A.R.) Shri R. Ganesh appeared before the department and case was discussed with him. During the course of hearing, details were sought for the deduction of INR 28,090 which were not submitted in stipulated time owing to which Department issued the Assessment order by making said disallowance and adjusting the same with losses reported in the return. Considering the immateriality of the amount involved and the facts of the case, the Company, based on careful assessment, decided not to pursue further appellate proceedings. Accordingly, the matter stands concluded.
2 Assistant Commissioner of Income Tax 19-Mar-2013 Company claimed loss of INR 2,63,44,28 while filing ITR. After filing the ITR, return was selected for scrutiny and notice u/s 142(1) was issued on 19th March 2013 requiring the Company to produce relevant books of accounts along with details of the total expenses of INR 4,19,64,645 Furthermore, the department contended that the expenditure relating to exempt income should be disallowed to the extent of INR 15,59,203 The Company submitted the requested details on 28th June 2013, indicating that out of the total expenses of INR 4,19,64,645, INR 1,41,13,678 was incurred for consultancy assignments, INR 6,49,753 for the Kochi Medcity project, and INR 2,72,01,213 for common expenses. However, the department took the view that the expenditure related to the Kochi Medcity project (INR 6,49,753) and 10% of the common expenses (pertaining to the project) amounting to INR 33,69,874 should be disallowed and capitalized. Regarding 14A disallowed, the Company has already disallowed the expenditure incurred for earning dividend income, amounting to INR 2,11,695. Accordingly, additional expenditure of INR 13,47,508 was disallowed. Assessment order was passed by making these two additions After due consideration of the merits and materiality, the Company elected not to file an appeal. The matter has attained finality.
3 Additional Commissioner of Income Tax 24-Mar-2015 The department issued a notice to the Company , stating that the return of income initially declared with a loss of INR 7,46,38,662 was revised to INR 7,33,26,546. The return was selected for scrutiny, and A.R. Shri R. Ganesh submitted the required details in person. The company earned consultancy, interest, and dividend income while developing the Kochi Medcity project. The department issued order u/s 143(3) on 24th March 2015and disallowed INR 10,05,637 for the project and 10% of common expenses (INR 72,74,942), directing these to be capitalized. Additionally, INR 39,40,093 related to exempt income (dividend and interest) was disallowed under Section 14A read with Rule 8D. After due consideration of the merits and materiality, the Company elected not to file an appeal. The matter has attained finality.
4 Assistant Commissioner of Income Tax 27-Dec-2019 The department issued a notice under sections 143(3) and 147 of the Income Tax Act, disallowing legal and professional fees and business promotion expenses of INR 6,63,07,001, citing no business nexus with operational income. The company appealed, arguing: Re-assessment was invalid as all material facts were disclosed. The reassessment was a change of opinion, supported by a Supreme Court ruling. 10% of expenses had already been disallowed. Company has filed appeal against Commissioner of Income Tax(CIT) citing above reason. The matter is currently under appeal with CIT(A), which is pending disposal
5 Assistant Commissioner of Income Tax 26-Feb-2016 The Department issued a notice to the Company stating that Company has filed return of income declaring total amount at Nil after set off BFDL amounts to INR 14,54,708. Return was selected for scrutiny and Notice u/s 142(1) dated 13th July 2015 was issued, against which AR Shri R. Ganesh from Rangamani & Co represented from time to time and submitted the required details. The department issued order on 26th Feb 2016 u/s 143(3) and disallowed INR 22,930 for the Kochi Medcity project, INR 25,12,379 of common expenses, and INR 50,55,986 related to exempt income under Rule 8D. After due consideration of the merits and materiality, the Company elected not to file an appeal. The matter has attained finality.
6 Assistant/Additional/Joint/Deputy Commissioner of Income Tax 30-Mar-2022 The department issued order under section 147 r.w.s. 144 and made disallowance of: i) INR 34,00,225 for expenditure related to exempt income under section 14A. ii) INR 10,15,430 for foreign exchange loss on machine import for the Aster Medcity project, which should be capitalized under section 43A. The order was passed u/s 147 r.w.s. 144 confirming the income as per order u/s 154 of INR 26 lakhs Considering the immateriality of the amount involved and the facts of the case, the Company, based on careful assessment, decided not to pursue further appellate proceedings. Accordingly, the matter stands concluded.
7 Deputy Commissioner of Income Tax 29-Dec-2016 The company received an assessment order on 29th Dec 2016, stating that FTC is not available for dividend received from Affinity Mauritius. However, the company follows the India-Mauritius tax treaty (Article 23), allowing FTC for Mauritian tax paid on dividends if the Indian company holds at least 10% of the Mauritian company’s shares. The company has obtained a legal opinion supporting this view. Department has disallowance the expenditure incurred to INR 1,33,53,573 on account of 14A, 43B of income tax etc. An appeal was filed on 27th Jan 2017, stating that the entire Mauritian tax payable should be eligible for FTC. The matter is currently under appeal with CIT(A), which is pending disposal
8 Deputy Commissioner of Income Tax 21-Dec-2017 The company received an assessment order on 21st Dec 2017, stating that FTC is not available for dividend received from Affinity Mauritius. However, the company follows the India-Mauritius tax treaty (Article 23), allowing FTC for Mauritian tax paid on dividends if the Indian company holds at least 10% of the Mauritian company’s shares. The company has obtained a legal opinion supporting this view. Department has disallowance the expenditure incurred to INR 1,86,53,445 on account of 14A, 43A, mismatch in 26AS etc. An appeal was filed against the CIT(A) on 25th Jan 2018, stating that the entire Mauritian tax payable should be eligible for FTC. The matter is currently under appeal with CIT(A), which is pending disposal
9 Deputy Commissioner of Income Tax 09-Mar-2021 The company received an assessment order on 31st March 2022 disallowing the expenditure such as ESOP expenses, deduction u/s 35AD, Expenditure in relation to exempt income, Foreign exchange fluctuation loss and income in relation to unbilled revenue which has already been taxed earlier result in double taxation on the same income in different assessment years. Company had filed appeal against the said disallowance at CIT(A) on 26th April 2022. The matter is currently under appeal with CIT(A), which is pending disposal
10 Deputy Commissioner of Income Tax 30-Dec-2019 The company received the order u/s 143(3) on 30th Dec 2019 making disallowance under Section 14A,. 35AD and 36(1)(va). The Company filed appeal against the said disallowance with CIT(A) on 21st Jan 2020 stating that company has already considered all the proposed disallowance. Disallowing the same again will result in double tax impact. The Assessment order was set aside by PCIT pursuant to order u/s 263 and accordingly CIT(A) stated that the appeal also stands null and void and accordingly dismissed the appeal Recently, Company received the Show cause Notice dated 18th March 2026 initiating penalty against the assessment order passed on 30th Dec 2019. The Company filed a detailed reply on 1st April 2026 stating that the assessment order has been set aside by PCIT and appeal has been disposed of as null and void and therefore the penalty proceedings against the assessment order dated 30th Dec 2019 is infructuous and has to be dropped. After filing the response to the penalty Show cause notice, no further update response from the department.
11 Deputy Commissioner of Income Tax 13-Mar-2023 The company has received the order u/s 143(3) r.w.s. 263 of Income tax Act on 13th March 2023 stated that payment related to EPF and PF amounting to INR 62,68,644 made after due date as specified under labour Acts. The Company has filed appeal against the said disallowance on 31st March 23 stated that delay in contribution is account of technical difficulties in the portal on account of ESI and EPF portal migration and there was no intention to make the remittance after the due date. The matter is currently under appeal with CIT(A), which is pending disposal
12 Assistant/Additional/Joint/Deputy Commissioner of Income Tax 24-Mar-2021 The company received notice u/s 143(3) on 24th March 2021 stating that Company has not disallowed the expenditure incurred for earning exempt income u/s 14A amounting to INR 5,84,34,120 and accordingly, the same was disallowed in the order Company filed the appeal against the disallowance with CIT(Appeal) stating that the disallowance made is not appropriate as company has Suo moto disallowed the expense under section 14A r.w.r 8D. The Assessment order was set aside by PCIT pursuant to order u/s 263 and accordingly CIT(A) stated that the appeal also stands null and void and accordingly dismissed the appeal Recently, the company received a show cause notice under Section 270A for AY 2018–19 on 10th Feb 2026 initiating penalty against the assessment order dated 24th March 2021. The Company filed a detailed reply on 12th Feb 2026 stating that the assessment order has been set aside by PCIT and appeal has been disposed of as null and void and therefore the penalty proceedings against the assessment order dated 24th Mar 2021 is infructuous and has to be dropped. After filing the response to the penalty Show cause notice, no further update response from the department.
13 Deputy Commissioner of Income Tax 30-Mar-2024 The company has received order u/s 143(3) on 30th March 24 which states that IPO proceeds are not utilised for the purpose for which it raised and hence share issue expense shall be disallowed. The Company is of the view that, even though IPO proceeds were utilised for repayment of loan, the end utilisation of the loan was towards expansion of Hospitals. Company has filed the appeal against the disallowance made at CIT(Appeal) authority level on 15th April 24 stated that the loan taken by the Company was towards expansion of the aforesaid hospitals. The matter is currently under appeal with CIT(A), which is pending disposal
14 Deputy Commissioner of Income Tax 26-Sep-2023 The company received multiple notices (u/s 142(1) and 143(2)) between June 2021 and July 2023 requesting documents for the return of income, which were submitted. On 26th Sep 2023, an order u/s 143(3) was issued disallowing INR 5,79,46,823 under section 14A. The company appealed on 10th Oct 2023, stating that the disallowance was unnecessary as it had already Suo-motu disallowed the expense under section 14A r.w.r 8D. Notice issued u/s 263 dated 26th December 2025 required company to represent before the department on 7th January 2026 in person or via authorised representative in relation to Sec 14A disallowance etc. which was attended personally scheduled at Kochi DGGI office on 7th January 2026 at 3:30 PM by Company's Tax consultant. The Assessment order was set aside by PCIT pursuant to order u/s 263 and accordingly CIT(A) stated that the appeal also stands null and void and accordingly dismissed the appeal Recently, Company received Penalty order dated 18th March 2026 against disallowance made in the assessment order dated 26th Sep 2023 having a demand of INR 1.06 Crores against which company has filed an appeal with CIT(A). It submits that the penalty is based on an assessment order dated 26.09.2023, which was subsequently set aside by the Principal Chief Commissioner of Income Tax under Section 263 on 05.03.2026 for fresh assessment. Since the underlying assessment order no longer exists, the penalty demand is a mistake apparent on record and has become infructuous. Accordingly, the company has requested that the penalty of INR 1.06 crore be quashed. After filing response to the Penalty order, no further update from the department.
15 Assessing Officer, Income Tax Circle 13-Nov-2022 Department has stated that company has not disallowed expenditure pertaining to INR 75.83 Crores pertaining to ICDS Disclosure, Sec 43B, Sec 23 of MSME etc. and raised demand amounting to INR 14.79 Crores. Company has filed an detailed response against the said demand on 14th Dec 2022. Further department has passed the rectification order nullifying the demand to Nil on 19th Feb 2025. Department has passed the rectification order nullifying demand to nil. The matter has attained finality
16 Assessing Officer, Income Tax Circle 22-Mar-2024 The company received intimation u/s 142(1) on 4th July 2023, 24th Dec 2023, and 1st Mar 2024, requesting documents, which were provided. On 22nd March 2024, a notice u/s 143(3) was issued, stating non-disallowance of INR 1,12,89,25,899 related to ICDS disclosure, Sec 43B, and Sec 40A(7), resulting in an IT demand of INR 36,02,08,230. The company filed a rectification application on 24th April 2024, citing disclosure differences. Further department has passed the rectification order nullifying the demand to Nil on 25th Feb 2025. Department has passed the rectification order nullifying demand to nil. The matter has attained finality
17 Additional Commissioner of Income Tax 06-Dec-2023 On 6th Dec 2023, the department issued a notice proposing a disallowance of INR 1,13,09,336 u/s 143(1)(a). The proposed adjustments included: a) INR 36,569 for employee contributions to welfare funds under section 36(1)(va), which the company stated had already been disallowed in the return of income filed. b) INR 1,12,72,767 for gratuity provision under section 40A(7), which the company also claimed was included in the total disallowance as per filed return. The company disagreed with the proposed adjustments, stating they had already been addressed. The response was duly accepted and intimation 143(1) was issued without any adjustments Since the order is favorable, no further action required from Company's side.
18 Deputy Commissioner of Income Tax 08-May-2024 The department has issued penalty show cause notice stated that company has not disallowed the Share issues expenses incurred on account of IPO issued. Management has filed the response against the said SCN on 22nd May 2024 stated that expenditure incurred by the Company are in the nature of underwriting commission, brokerage and charges for drafting, typing, printing and advertisement of the prospectus which qualify to claim u/s 35AD. Hence, penalty proceeding shall not be initiated till the disposal of appeal preferred against CIT(Appeal). After submitting the response, no communication received from the department.
19 National faceless assessment centre 19-Dec-2024 Notice required the company to provide the summary of transaction entered with Mr. Hameed and relevant bank statement, ledger account and total fees paid to Assessee to support these transactions by 24th Dec 2024. Company has responded to the above notice by responding over the mail on 7th Jan 2025 After submitting the response, no communication received from the department.
20 Assessment Unit/Verification Unit/Technical Unit/Review Unit of Income Tax department 20-Dec-2024 Notice issued for Sec. 142(1) dated 20th Dec 2024 to produce certain books of account. Company has submitted the required set of documents as asked in Income Tax portal on 6th Jan 2025. After submitting the documents, no communication received from the department.
21 National faceless assessment centre 24-Dec-2024 Notice required the company to provide the details of payment made to Mr. Sumon Khan along with invoice and mode of payment. Company has responded to the above notice by responding over the mail on 21st Jan 2025. After submitting the response, no communication received from the department.
22 Income Tax Authority 27-Dec-2024 Notice served in IT portal on 27th Dec 2024 for proposed ICDS adjustment made in ITR filed for FY 23-24. Company has submitted the responses on 3rd Jan 2025 stating that all proposed adjustment has already been made and hence making the adjustment again will have twice impact. After submitting the response, no communication received from the department.
23 National faceless assessment centre 10-Jan-2025 Notice required the company to provide the details of contract and rent payment made to Mr. TIJO TOMY CHIRAKARA along with agreement entered and ledger of the above mentioned Assessee and mode of payment. Further, company was not able to file the response since there was no path mentioned in the notice regarding the submission even though company is ready with all the required set of documents. Further, we have raised grievance issue also regarding the same on that day. No further update received from the department after raising grievance.
24 Income Tax Authority 05-Jun-2025 Company has received intimation u/s 143(1) on 5th June 2025 where department is of the contention that there is difference in TDS credit available as per 26AS and TDS credit availed while filing ITR for FY 23-24. Company has provided the response via mail on 28th June 2025.
25 Income Tax Authority 23-Jun-2025 Company has received notice to produce the ITR and ITR acknowledgement. We have provided the requested details over the portal on 3rd July 2025.
26 Income Tax Authority 08-Oct-2025 Department has issued notice stating that since the appeal has been filed for subsequent proceeding and order passed u/s 263 hence appeal filed against first proceeding shall stand void. No action is required to be taken from management side.
27 National faceless assessment centre 17-Nov-2025 Notice issued to the company to provide the nature of technical or professional service rendered by Assessee named Mr.Rangenahalli Udayakumar Divya along with agreement entered and ledger of the above mentioned Assessee and bank statement and copy of ITR. Company has submitted the details over the portal on 24th November 2025.
28 National faceless assessment centre 17-Nov-2025 Notice issued to the company to provide the nature of transaction or service rendered by Assessee named Mrs. Preetha Prakash Naik along with details of TDS deducted and mode of payment and copy of agreement and ledger of the above mentioned Assessee. Company has submitted the details over the portal on 16th December 2025.
29 Principal Commissioner of Income Tax (PCIT) 26-Dec-2025 Notice issued u/s 263 dated 26th December 2025 required company to represent before the department on 7th January 2026 in person or via authorised representative in relation to ICDS disclosure, Sec 43B, and Sec 40A(7) Mr. Ganesh from Rangamani & Co. who is Tax consultant of the group had attended the personal hearing scheduled at Kochi DGGI office on 7th January 2026 at 3:30 PM.
30 Office of the Deputy Commissioner of Income Tax(DCIT) 13-Mar-2026 Notice issued u/s 92CA(2) dated 13th March 2026 required the company to produce details related to international transaction such as TPO order, Form 3CEB etc. against which the Company has filed the response on 9th April 2026 After filing response to the notice, no further update from the department.
31 Commissioner of Income Tax, TDS 17-Mar-2026 Proceedings under Section 201 were initiated, wherein the department sought details such as financial statements, tax audit report, TDS returns, and classification of doctor payouts under Sections 192 vs 194J. The matter was discussed with the CIT (TDS), who raised queries on the nature of transactions and differences between tax audit and financials, all of which were satisfactorily explained. The CIT(TDS) accepted the submissions and issued a Nil demand order on 17th March 2026 Since the order is favourable, no further action required from Company's side.
32 Assistant Commissioner of Income Tax 09-Mar-2021 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
33 Assistant Commissioner of Income Tax 25-Jul-2023 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
34 Assistant Commissioner of Income Tax 19-Jan-2024 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
35 Assistant Commissioner of Income Tax 19-Mar-2024 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
36 Assistant Commissioner of Income Tax 12-Jun-2024 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
37 Assistant Commissioner of Income Tax 26-Jul-2024 The Company has adopted a view that payment to doctors is liable to TDS under section 194J of the Act on account of the following : a) No employment contract with the Doctors b) Doctors are not entitled to employee benefits as per contract and expressly mentioned in the agreement that there is no employer employee relationship c) No prohibition/ bar on the doctors to be associated with other hospitals. d) No restriction on the nature of work that doctors perform in Aster DM e) Aster DM exercises no disciplinary control over doctors f) Contract with doctors is a Contract for service and not contract of service In a similar case in Manipal Health Systems Ltd vs CIT (Karnataka High Court (2015) reported in ITANO.747/2009 c/w ITA NO. 746/2009, the Karnataka High Court observed that contract between the Assessee and doctors was not a Contract of Service but Contract for service and therefore the payments made to doctors by the hospital are covered under section 194J. Given the above and review of submissions filed supported by multiple judicial precedents, a view may be adopted that the Company shall deduct TDS on payment to doctors under section 194J of the Act considering that primarily, there is no employer-employee relationship along with other grounds as given by the Company. Further company has filed appeal with the CIT(A) with respect to the said demand raised and paid 20% of the demand amount as we want to obtained LDC and department insisted us to pay that amount in order to provide LDC. Further, company has received favourable order from CIT(A) for AY 2018-19, 2019-20, 2020-21 and 2021-22 on 24th Dec 2024 stating that TDS deducted u/s 194J is appropriate and raised demand has been dropped. Accordingly company is eligible for refund amount for the amount which they already paid. Further, Company has received notice from the ITAT where they required management to appear for personal hearing at Kochi office. The hearing was attended by Mr. Krishnan (Senior Partner) of Rangamani & Co. Department has dropped the demand for AY 2018-19 to 2021-22.
38 Assistant Commissioner of Income Tax 18-Jun-2025 The Income Tax Department issued a notice to the company on 18th June 2025, stating that the Company had reported 242 payments in the Tax Audit Report for FY 2018–19, wherein TDS amounting to INR 82.13 lakhs was not deducted. The Department has sought clarification on whether such payments were subsequently made or reversed in the following year. The company was scheduled to attend a personal hearing on 3rd July 2025. The company has provided the response over the portal.
39 Commercial tax officer 21-Jun-2024 ASMT-10 and DRC-01A issued with respect to difference in output tax liability declared in GSTR 1 and 3B return amounting to INR 19,09,920 The notices enquired about the reason for difference in output tax liability between GSTR 1 and GSTR 3B returns for the period FY 2022-23. Reply to the SCN filed by the Company online along with supporting documents on 18th July 2024 stated that there is only shortfall of INR 36,000 which has been paid along with interest amounting to INR 8,007 as applicable. After submitting the response, no communication received from the department.
40 Commercial tax officer 16-Nov-2023 Summon issued under section 70 of CGST Act, 2017 - Query with respect to IPO: The department has issued summon requiring necessary attendance for giving evidence and requesting to submit the following documents through personal attendance: 1. Details of IPO released by the Company 2. Value of IPO and date of release to the market 3. Details of ITC reversed by the company that has raised funds through initial public offering since April 2018. The Company filed a reply to the department vide letter dated 16th November 2023 with respect to ITC reversal on IPO expenses. The filed reply states that the Company has not utilized any ITC pertaining to IPO expenses and all those credits has been already reversed by the Company. After submitting the response, no communication received from the department.
41 The Senior Intelligence Officer, DGGI 01-Feb-2024 Summon issued under section 70 of CGST Act, 2017 - GST on Corporate Guarantee: The department has issued summon requiring personal attendance and requested to submit the certain set of document required as stated in the notice. The Company represented itself before the Department and have submitted preliminary information with respect to GST paid on Corporate Guarantee. After submission of the response, no further communication received from the department.
42 Additional Director of Central Goods and Service Tax 16-Jul-2024 SCN issued under Section 74 of CGST Act, 2017- GST on Covid vaccination The SCN enquired about non-payment of GST for covid vaccination. The SCN was issued to the Company as a whole (including Kerala registration). The company has filed response stated that we are not paying the amount since it is considered as healthcare service and should be treated as a composite supply to healthcare services. Further company has asked for personal hearing for issue and sent response on 8th of August 2024 via post. Further, company has received demand order on 19th March 2025 amounting to INR 1.08 Crores along with penalty amounting to 100%. Company has filed the appeal against the said demand on 14th June 2025 stating the facts to the GST Authority and paid 10% pre-deposit amount of demand raised to file the appeal to the Appellate authority. Also, the response has been filed offline at the GST office, Koramangala. Company has filed the appeal against the Assistant Commissioner order on 14th June 2025. After filing the appeal, no further communication from the department.
43 Assistant Commissioner of Commercial Taxes 26-Jun-2024 Form GST ADT - 01 notice issued for conducting department audit under Section 65 of CGST Act, 2017: The department has issued notice to produce certain document for initiation of Department audit like GSTR return working, RCM register etc. Further department has various set of document to complete the audit which has been produced by the company. Department has asked management to represent before the department. After representation, department has issued audit observation letter and raised demand of Rs. 69 lakhs against which company has responded. After responded against the audit observation letter, department has dropped the demand raised. Case has been closed by the department.
44 Department of commercial taxes 25-Nov-2024 Summon issued by Tax authority on dated 25.11.2024 : Department has issued summon seeking information//documents/clarifications like sales and purchase register, GSTR 9 and 9C working, reconciliation of 1 vs 3b etc. for period between FY 2020-21 till FY 24-25. Company has represented before the tax authority physically on dated 30.11.2024 and provided the documents as required. After the document provided by the company, there has been no further communication from the department.
45 Assistant commissioner of Central Goods and Service Tax 16-Nov-2024 SCN notice issued on supply made to DM Medcity SEZ unit : Department has stated that supply made to SEZ will not be treated as Zero rated supply since no proper documentation maintained. Management has represented before the department on 18th Dec 24 and stated that supply made to SEZ unit should be treated as Zero rated supply and no GST payable on the same. Further we have LUT also for the year for supporting our view. Department has accepted the view and dropped the demand. Case has been closed by the department.
46 Additional Director of Central Goods and Service Tax 03-Jan-2024 Show Cause Notice issued by DGGI - GST on Accommodation provided to Bystanders: SCN alleges that Aster has not paid taxes on accommodation services provided to bystanders and outpatients in their guest accommodation 'Aster Suites'. The department alleged that accommodation services provided at Aster Suites is similar to accommodation at hotels and hence they are taxable. However, the Company has taken the position that accommodation services is part of composite supply of healthcare services wherein bystander accommodation is ancillary or integral to the healthcare services being rendered. However, department has issued the order on 26th Dec 2024 which is not in the favour of Company and raised demand amounting to INR 2.91 Crores along with penalty of 100%. Company has filed the appeal against the said demand on 24th March 2025 stating the facts to the GST Authority and paid 10% pre-deposit amount of demand raised to file the appeal to the Appellate authority. After filing the appeal, no further communication from the department. Company has filed the appeal to the higher authority against the order on 24th March 2025. No further update received from the concerned authority
47 Deputy commissioner of Goods and Service tax 22-Jul-2024 Notice for conducting department audit under Section 65 of CGST Act, 2017: Notice for conducting department audit under Section 65 of CGST Act, 2017 for the FY 2018-19 to FY 2022-23 issued. Company has produced the document required for audit purpose. After submission of the documents, no further communication received from the department.
48 Director General of GST Intelligence 19-Nov-2024 Requisition of certain information by issuing notice dated 19th November 2024 : Department has conducted enquiry on Stake Sale in M/s Aster DM Healthcare Limited and request for certain set of documents. Company was requested to submit SPA, SHA, Promotional agreement and other document relevant to the stake sale. Company filed response against the same to the Department on dated 26th November 2024 via mail. After submission of the documents, no further communication received from the department.
49 Assistant Commissioner of Commercial Taxes 15-Mar-2025 ASMT-10 issued with respect to difference in ITC claimed in GSTR 3B and ITC available in GSTR 2A: The notices enquired about the reason for difference in ITC claimed in GSTR 3B and ITC available in GSTR 2A for the period FY 2023-24. Company has submitted the documents on 23rd May 2025 over the portal.
50 Assistant Commissioner of Commercial Taxes 31-May-2025 Form GST ADT - 01 notice issued for conducting department audit under Section 65 of CGST Act, 2017 : The department has issued notice to produce certain document for initiation of Department audit like GSTR return working, RCM register etc. Company has submitted the initial set of documents via portal on 15th June 2025. Company has taken two month of adjournment for submitting the pending details. Further company has submitted the remaining documents on 23rd August 2025. Post submission of details, department has issued audit observation letter for FY 21-22 where they have identified certain discrepancies on 11th Sep 2025. Management has provided the relevant details on 18th September 2025. Post submission of clarification for audit observation, department has dropped the proceeding for FY 21-22 on 26th Sep 2025.
51 Assistant Director of Commercial taxes 29-Sep-2025 GST Show cause notice and demand order issued for Aster DM Kerela GST registration under section 74(1) of CGST Act, 2017: The department has issued notice to the company requiring the reason to state that why the GST has not been paid on insurance processing fees collected from patient from FY 2019-20 to 2023-24. The company submitted its response on the portal on 29th October 2025. Subsequently, the department issued a demand order dated 24th March 2026, holding the company liable to pay GST on insurance processing fees. A demand of INR 0.36 crore has been raised along with a 100% penalty. The company is currently evaluating the order and contemplating to file an appeal at the appropriate level.
52 Assistant Director of Commercial taxes 06-Oct-2025 Notice for conducting department audit under Section 65 of CGST Act, 2017: Notice for conducting department audit under Section 65 of CGST Act, 2017 for the FY 2022-23 issued. Company have submitted the required details to the department over the mail. Post submission of details, Company is yet to receive further communication from the department.